Hipercalcemia causada por inyección subcutánea con metacrilato

Contenido principal del artículo

Francisco Rodolfo Spivacow

Detalles del artículo

Cómo citar
1.
Spivacow FR. Hipercalcemia causada por inyección subcutánea con metacrilato. Rev Nefrol Dial Traspl. [Internet]. 1 de diciembre de 2016 [citado 26 de febrero de 2021];36(4):235-40. Disponible en: http://www.revistarenal.org.ar/index.php/rndt/article/view/93
Sección
Casuística

Citas

1) Donovan PJ, Sundac L, Pretorius CJ, D’Emden MC, McLeod DS. Calcitriol-mediated hypercalcemia: causes and course in 101 patients. J Clin Endocrinol Metab. 2013;98(10):4023-9.

2) Garabédian M, Jacqz E, Guillozo H, Grimberg R, Guillot M, Gagnadoux MF, et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N Engl J Med. 1985;312(15):948-52.

3) Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg. 2011;81(1-2):9-17.

4) Oppenlander ME, Bina R, Snyder LA, Dickman CA. Intravertebral polymethylmethacrylate augmentation of anterior cervical discectomy fusion and plating in the setting of osteoporosis. J Spinal Disord Tech. 2014;27(3):185-8.

5) Jo JY, Kang SH, Park SW. Modified polymethylmethacrylate cervical plate and screw augmentation technique for intraoperative screw loosening. J Spinal Disord Tech. 2012;25(4):235-9.

6) Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg. 2010;18(5):297-305.

7) Webb JC, Spencer RF. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J Bone Joint Surg Br. 2007;89(7):851-7.

8) Lee YB, Song EJ, Kim SS, Kim JW, Yu DS. Safety and efficacy of a novel injectable filler in the treatment of nasolabial folds: polymethylmethacrylate and cross-linked dextran in hydroxypropyl methylcellulose. J Cosmet Laser Ther. 2014;16(4):185-90.

9) Lemperle G, Sadick NS, Knapp TR, Lemperle SM. ArteFill permanent injectable for soft tissue augmentation: II. Indications and applications. Aesthetic Plast Surg. 2010;34(3):273-86.

10) Medeiros CC, Cherubini K, Salum FG, De Figueiredo MA. Complications after polymethylmethacrylate (PMMA) injections in the face: a literature review. Gerodontology. 2014;31(4):245-50.

11) Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg. 2008;121(5):1811-20.

12) Wu W, Chayavichitsilp P, Hata T. Extremely delayed granulomatous reaction to soft-tissue injectables (polymethyl methacrylate). J Am Acad Dermatol. 2012;67(5):e206-7.

13) Negri AL, Rosa Diez G, Del Valle E, Piulats E, Greloni G, Quevedo A, et al. Hypercalcemia secondary to granulomatous disease caused by the injection of methacrylate: a case series. Clin Cases Miner Bone Metab. 2014;11(1):44-8.

14) Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103(3-5):316-21.

15) Lewiecki EM. Clinical use of denosumab for the treatment for postmenopausal osteoporosis. Curr Med Res Opin. 2010;26(12):2807-12.